Lesion-level characteristics | Sirolimus- and probucol-eluting stent (n = 849) | Zotarolimus-eluting stent (n = 439) | P value |
---|---|---|---|
Balloon diameter (mm) | 3.05 (2.59–3.47) | 3.02 (2.60–3.45) | 0.82 |
Stented length (mm) | 25 (18–34) | 24 (18–33) | 0.23 |
In stent analysis | |||
Post-procedural minimal luminal diameter (mm) | 2.50 ± 0.50 | 2.57 ± 0.49 | 0.045 |
Post-procedural percent diameter stenosis (%) | 12 ± 7 | 11 ± 7 | 0.03 |
At follow-up minimal luminal diameter (mm)a | 2.13 ± 0.73 | 2.20 ± 0.72 | 0.18 |
At follow-up percent diameter stenosis (%)a | 24 ± 22 | 23 ± 21 | 0.68 |
Late lumen loss (mm)a | 0.36 ± 0.63 | 0.36 ± 0.59 | 0.48 |
In segment analysis | |||
Post-procedural minimal luminal diameter (mm) | 2.23 ± 0.58 | 2.26 ± 0.55 | 0.33 |
Post-procedural percent diameter stenosis (%) | 22 ± 12 | 22 ± 12 | 0.83 |
At follow-up minimal luminal diameter (mm)a | 1.90 ± 0.70 | 1.98 ± 0.69 | 0.10 |
At follow-up percent diameter stenosis (%)a | 33 ± 20 | 32 ± 19 | 0.20 |
Late lumen loss (mm)a | 0.31 ± 0.61 | 0.26 ± 0.57 | 0.34 |
Binary restenosisa | 107 (17.0) | 57 (17.2) | 0.95 |